Yıl: 2020 Cilt: 22 Sayı: 2 Sayfa Aralığı: 233 - 239 Metin Dili: İngilizce DOI: 10.24938/kutfd.705435 İndeks Tarihi: 07-06-2021

CD44 EXPRESSION IN PROSTATIC ADENOCARCINOMA: CORRELATION WITH GLEASON GRADES

Öz:
Objective: CD44, a cell-surface adhesion protein, is a marker ofstem cells and is involved in the structural maintenance ofprostate gland basal cells. It plays an important role in prostatecarcinogenesis; however, research results till date have beeninconsistent. The current study was conducted to evaluate theexpression level of CD44 among carcinomas with differentGleason growth patterns and hyperplastic glands.Material and Methods: Eighty archival tissue samples frompatients with either prostate carcinoma of differing Gleasonpatterns or benign prostate hyperplasia from the pathologyarchives of the Kırıkkale University, Faculty of Medicine, from2011 to 2018 were included. Immunoreaction to CD44antibodies was evaluated by calculating positively stained cellpercentage and staining intensity. Mean values and significancewere determined using the Kruskal–Wallis test. p<0.05 wasconsidered significant.Results: CD44 staining was more diffuse and intense in most ofbenign hyperplastic tissues compared to carcinoma cases (pvalues ranged from <0.01 to 0.005). Expression level graduallydecreased with increasing severity of histologic pattern. Pattern3 tumor showed higher percentage of positively stained cellsthan pattern 4 (p<0.01) There was no positivity with CD44 ingrade 5 tumours. Also, in pattern 4 only few cells reacted withCD44. There was no statistically significant difference in thestaining score between pattern 4 and 5 (p=0.278).Conclusion: We conclude that once cancerous properties havebeen established, cells tend to lose the ability of CD44expression. CD 44 expression in low grade carcinomas suggestthat CD 44 maintains the tumor in a differentiated, glandforming state so it may not act as a cancer stem cell marker inprostate carcinogenesis.
Anahtar Kelime:

Prostat Adenokarsinomunda CD44 Ekspresyonu: Gleason Derecesi ile Korelasyon

Öz:
Amaç: Bir yüzey adezyon proteini olan CD44, kök hücre belirteci olup prostat glandlarının bazal hücrelerinin yapısal bütünlüğünü korumada görev alır. Prostat karsinogenezisinde de önemli bir rolü olduğu düşünülse de şu ana dek yapılan çalışmalarda elde edilen sonuçlar belirsizdir. Bu çalışma, farklı Gleason büyüme patternlerine sahip tümörlerde ve hiperplastik glandlarda CD44 ekspresyonunu değerlendirmek amacı ile yapılmıştır. Gereç ve Yöntemler: Kırıkkale Üniversitesi, Tıp Fakültesi patoloji arşivine ait, 2011 ile 2018 yılları arasında tanı almış, farklı Gleason derecelerine sahip prostat karsinomlu ve benign prostat hiperplazili 80 olgu, çalışmaya dahil edilmiştir. CD44 ile olan immünreaksiyon, pozitif boyanan hücrelerin yüzdesi ile boyanma yoğunluğunun çarpımı olarak değerlendirilmiştir. Ortalama değerler ve anlamlılık Kruskal-Wallis testi kullanılarak belirlenmiş; p<0.05 anlamlı kabul edilmiştir. Bulgular: Benign hiperplazi olgularında CD44 boyanması, karsinom olgularına göre daha diffüz ve yoğun idi (p değerleri <0.01-0.005). Ekspresyon seviyesi, histolojik derece arttıkça kademeli olarak düşüş gösterdi. Pattern 3 tümörler, pattern 4 tümörlerden daha yüksek oranda pozitif hücre sayısına sahipti (p<0.01). Pattern 5 tümörlerde CD44 ile boyanma olmadı. Pattern 4 tümörlerde ise az sayıda hücrede pozitiflik görüldü. Pattern 4 ve 5 arasında, CD44 boyanması bakımından anlamlı farklılık gözlenmedi ((p=0.278). Sonuç: Bu çalışmada, bir kez kanseröz özellikler kazanıldıktan sonra hücrelerin CD44 ekspresyonu kabiliyetini yitirme eğiliminde olduğu sonucuna vardık. Düşük dereceli kanserlerdeki CD44 ekspresyonunun, tümör dokusunu diferansiye ve gland oluşturabilen durumda kalmasını sağladığını, bu nedenle CD44’ün prostat karsinogenezisinde bir tümör kök hücre marker’ı gibi davranmayabileceğini düşündük.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424.
  • 2. Crona DJ, Whang Y. Androgen receptor-dependent and -independent mechanisms involved in prostate cancer therapy resistance. Cancers (Basel). 2017;9(6):67.
  • 3. Chen C, Zhao S, Karnad A, Freeman JW. The biology and role of CD44 in cancer progression: therapeutic implications. J Hematol Oncol. 2018;11(1):64.
  • 4. Harris KS, Kerr BA. Prostate cancer stem cell markers drive progression, therapeutic resistance, and bone metastasis. Stem Cells Int. 2017;(2):1-9.
  • 5. Kalantari E, Asgari M, Nikpanah S, Salarieh N, Asadi Lari MH, Madjd Z. Co-Expression of putative cancer stem cell markers CD44 and CD133 in prostate carcinomas. Pathol Oncol Res. 2017;23(4):793-802.
  • 6. Mizukami T, Kamachi H, Mitsuhashi T, Tsuruga Y, Hatanaka Y, Kamiyama T et al. Immunohistochemical analysis of cancer stem cell markers in pancreatic adenocarcinoma patients after neoadjuvant chemoradiotherapy. BMC Cancer 2014;14:687.
  • 7. Rich JN. Cancer stem cells: understanding tumor hierarchy and heterogeneity. Medicine (Baltimore). 2016;95(Suppl 1):S2-S7.
  • 8. Zhao W, Li Y, Zhang X. Stemness-Related Markers in Cancer. Cancer Transl Med. 2017;3(3):87-95.
  • 9. Wang Y, Hayward S, Cao M, Thayer K, Cunha G. Cell differentiation lineage in the prostate. Differentiation 2001;68(4):270-9.
  • 10. Trompetter M, Smedts F, van der Wijk J, Schoots C, de Jong HJ, Hopman A et al. Keratin profiling in the developing human prostate. A different approach to understanding epithelial lineage. Anticancer Res 2008;28(1A):237-43.
  • 11. Kwon O, Xin L. Prostate epithelial stem and progenitor cells. Am J Clin Exp Urol. 2014;2(3):209-18.
  • 12. Draffin JE, McFarlane S, Hill A, Johnston PG, Waugh DJ. CD44 potentiates the adherence of metastatic prostate and breast cancer cells to bone marrow endothelial cells. Cancer Res 2004;64(16):5702-11.
  • 13. Lokeshwar BL, Lokeshwar VB, Block NL. Expression of CD44 in prostate cancer cells: association with cell proliferation and invasive potential. Anticancer Res 1995;15(4):1191-8.
  • 14. Shang Z, Cai Q, Zhang M, Zhu S, Ma Y, Sun L et al. Switch from CD44+ cell to EMT cell drives the metastasis of prostate cancer. Oncotarget 2015;6(2):1202-16.
  • 15. Verkaik NS, van Steenbrugge GJ, van Weerden WM, Bussemakers MJ, van der Kwast TH. Silencing of CD44 expression in prostate cancer by hypermethylation of the CD44 promoter region. Lab Invest 2000;80(8):1291-8.
APA Balcı M, Ozdemir G (2020). CD44 EXPRESSION IN PROSTATIC ADENOCARCINOMA: CORRELATION WITH GLEASON GRADES. , 233 - 239. 10.24938/kutfd.705435
Chicago Balcı Mahi,Ozdemir Gulhan CD44 EXPRESSION IN PROSTATIC ADENOCARCINOMA: CORRELATION WITH GLEASON GRADES. (2020): 233 - 239. 10.24938/kutfd.705435
MLA Balcı Mahi,Ozdemir Gulhan CD44 EXPRESSION IN PROSTATIC ADENOCARCINOMA: CORRELATION WITH GLEASON GRADES. , 2020, ss.233 - 239. 10.24938/kutfd.705435
AMA Balcı M,Ozdemir G CD44 EXPRESSION IN PROSTATIC ADENOCARCINOMA: CORRELATION WITH GLEASON GRADES. . 2020; 233 - 239. 10.24938/kutfd.705435
Vancouver Balcı M,Ozdemir G CD44 EXPRESSION IN PROSTATIC ADENOCARCINOMA: CORRELATION WITH GLEASON GRADES. . 2020; 233 - 239. 10.24938/kutfd.705435
IEEE Balcı M,Ozdemir G "CD44 EXPRESSION IN PROSTATIC ADENOCARCINOMA: CORRELATION WITH GLEASON GRADES." , ss.233 - 239, 2020. 10.24938/kutfd.705435
ISNAD Balcı, Mahi - Ozdemir, Gulhan. "CD44 EXPRESSION IN PROSTATIC ADENOCARCINOMA: CORRELATION WITH GLEASON GRADES". (2020), 233-239. https://doi.org/10.24938/kutfd.705435
APA Balcı M, Ozdemir G (2020). CD44 EXPRESSION IN PROSTATIC ADENOCARCINOMA: CORRELATION WITH GLEASON GRADES. Kırıkkale Üniversitesi Tıp Fakültesi Dergisi, 22(2), 233 - 239. 10.24938/kutfd.705435
Chicago Balcı Mahi,Ozdemir Gulhan CD44 EXPRESSION IN PROSTATIC ADENOCARCINOMA: CORRELATION WITH GLEASON GRADES. Kırıkkale Üniversitesi Tıp Fakültesi Dergisi 22, no.2 (2020): 233 - 239. 10.24938/kutfd.705435
MLA Balcı Mahi,Ozdemir Gulhan CD44 EXPRESSION IN PROSTATIC ADENOCARCINOMA: CORRELATION WITH GLEASON GRADES. Kırıkkale Üniversitesi Tıp Fakültesi Dergisi, vol.22, no.2, 2020, ss.233 - 239. 10.24938/kutfd.705435
AMA Balcı M,Ozdemir G CD44 EXPRESSION IN PROSTATIC ADENOCARCINOMA: CORRELATION WITH GLEASON GRADES. Kırıkkale Üniversitesi Tıp Fakültesi Dergisi. 2020; 22(2): 233 - 239. 10.24938/kutfd.705435
Vancouver Balcı M,Ozdemir G CD44 EXPRESSION IN PROSTATIC ADENOCARCINOMA: CORRELATION WITH GLEASON GRADES. Kırıkkale Üniversitesi Tıp Fakültesi Dergisi. 2020; 22(2): 233 - 239. 10.24938/kutfd.705435
IEEE Balcı M,Ozdemir G "CD44 EXPRESSION IN PROSTATIC ADENOCARCINOMA: CORRELATION WITH GLEASON GRADES." Kırıkkale Üniversitesi Tıp Fakültesi Dergisi, 22, ss.233 - 239, 2020. 10.24938/kutfd.705435
ISNAD Balcı, Mahi - Ozdemir, Gulhan. "CD44 EXPRESSION IN PROSTATIC ADENOCARCINOMA: CORRELATION WITH GLEASON GRADES". Kırıkkale Üniversitesi Tıp Fakültesi Dergisi 22/2 (2020), 233-239. https://doi.org/10.24938/kutfd.705435